BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/12/2023 9:46:15 AM | Browse: 517 | Download: 1290
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 82684
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Immuno-oncology-microbiome axis of gastrointestinal malignancy
Manuscript Source Invited Manuscript
All Author List Quan Lin, Shi-Wei Guan and Hai-Bo Yu
Funding Agency and Grant Number
Corresponding Author Hai-Bo Yu, MD, Chief Doctor, Department of Surgery, Wenzhou Central Hospital, The Dingli Clinical Institute of Wenzhou Medical University, No. 252 Baili East Road, Wenzhou 325000, Zhejiang Province, China. yuhaibozjwz@163.com
Key Words Gut microbiome; Intratumor microbiome; Gastrointestinal malignancy; Tumor microenvironment; Immunity; Therapy
Core Tip The gut and intratumor microbiome can influence tumor progression by modulating host metabolism and the immune and immune tone of the tumor microenvironment, which is defined as the immuno-oncology-microbiome (IOM) axis. The proposed the IOM axis provides a new target for tumor microbiome and tumor immunity. Current studies have shown that immunotherapy with fecal microbiota transplantation or microbial metabolism have certain effects. This review aims to explore the mechanism of the IOM axis of gastrointestinal malignancies, to reveal the mechanism and progress of gut and intratumor microbiome in gastrointestinal malignancies. Providing new insights into the research related to gastrointestinal malignancies.
Publish Date 2023-05-12 09:13
Citation Lin Q, Guan SW, Yu HB. Immuno-oncology-microbiome axis of gastrointestinal malignancy. World J Gastrointest Oncol 2023; 15(5): 757-775
URL https://www.wjgnet.com/1948-5204/full/v15/i5/757.htm
DOI https://dx.doi.org/10.4251/wjgo.v15.i5.757
Full Article (PDF) WJGO-15-757.pdf
Full Article (Word) WJGO-15-757.docx